Overview
Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania.
Dr. Olin is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. She is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 1 clinical trial. Dr. Olin is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave., Fourth Floor, San Francisco, CA 94143
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Cutaneous Lymphoma Clinic
Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), T-Cell Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Ai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ai is currently accepting new patients.
UCSF Benioff Children's Hospital Oakland
Elliott Vichinsky is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vichinsky is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.
Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Vitrectomy, and Bone Marrow Aspiration. Dr. Rubenstein is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Rubenstein is currently accepting new patients.
Frequently Asked Questions about Dr. Rebecca L. Olin
How do I make an appointment with Dr. Rebecca L. Olin?
You can book an appointment with Dr. Rebecca L. Olin by calling their office at 415-353-2051. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rebecca L. Olin a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rebecca L. Olin is classified as an Elite expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rebecca L. Olin specialize in?
While Dr. Rebecca L. Olin is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Rebecca L. Olin participate in research or clinical trials?
Yes. Dr. Rebecca L. Olin has published 76 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Rebecca L. Olin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rebecca L. Olin accept my insurance?
Dr. Rebecca L. Olin accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 415-353-2051 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Olin isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Childhood Acute Myeloid LeukemiaDr. Olin isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Multiple MyelomaDr. Olin isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Olin isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acquired Amegakaryocytic Thrombocytopenia
- Acute Monoblastic Leukemia (AmoL)
- Acute Promyelocytic LeukemiaDr. Olin isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Aplastic AnemiaDr. Olin isAdvanced. Learn about Aplastic Anemia.
- Ataxia-Pancytopenia SyndromeDr. Olin isAdvanced. Learn about Ataxia-Pancytopenia Syndrome.
- Bone Marrow TransplantDr. Olin isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Acute Febrile Neutrophilic Dermatosis
- Acute Mountain SicknessDr. Olin isExperienced. Learn about Acute Mountain Sickness.
- Acute Myelomonocytic LeukemiaDr. Olin isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Olin isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Olin isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Olin isExperienced. Learn about Anaplastic Large Cell Lymphoma.